ACADIA Pharmaceuticals Inc (ACAD)
16.18
-0.09
(-0.55%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
+0.02
(+0.09%)
After-Hours: 20:00
ACADIA Pharmaceuticals Gross Profit Margin (Quarterly): 92.47% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 92.47% |
| June 30, 2024 | 92.47% |
| March 31, 2024 | 88.85% |
| December 31, 2023 | 92.26% |
| September 30, 2023 | 93.09% |
| June 30, 2023 | 95.49% |
| March 31, 2023 | 98.59% |
| December 31, 2022 | 98.23% |
| September 30, 2022 | 98.37% |
| June 30, 2022 | 98.02% |
| March 31, 2022 | 97.45% |
| December 31, 2021 | 98.04% |
| September 30, 2021 | 94.92% |
| June 30, 2021 | 95.48% |
| March 31, 2021 | 95.60% |
| December 31, 2020 | 95.62% |
| September 30, 2020 | 96.02% |
| Date | Value |
|---|---|
| June 30, 2020 | 95.03% |
| March 31, 2020 | 94.48% |
| December 31, 2019 | 94.58% |
| September 30, 2019 | 95.04% |
| June 30, 2019 | 94.00% |
| March 31, 2019 | 92.73% |
| December 31, 2018 | 92.63% |
| September 30, 2018 | 90.78% |
| June 30, 2018 | 91.10% |
| March 31, 2018 | 92.87% |
| December 31, 2017 | 91.50% |
| September 30, 2017 | 90.97% |
| June 30, 2017 | 89.48% |
| March 31, 2017 | 80.78% |
| December 31, 2016 | 80.67% |
| September 30, 2016 | 74.94% |
| June 30, 2016 | -697.9% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.85%
Minimum
Mar 2024
98.59%
Maximum
Mar 2023
95.25%
Average
95.48%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 75.13% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.32% |
| Return on Assets | 15.57% |
| Return on Invested Capital | 27.32% |
| Profit Margin (Quarterly) | 13.08% |
| Operating Margin (Quarterly) | 12.64% |
| Return on Net Operating Assets | 37.41% |